ASSOCIATE PROFESSOR PHILIP BEALE
ANZGOG – Chair of ANZGOG, Ex Officio on all Committees, Chair Operations Executive Committee and OASIS, Chair Ovarian Tumour Group
Associate Professor Beale is Director of Cancer Services and Director of Palliative Care, Sydney Local Health District, Head of Medical Oncology Department at Concord Hospital, Senior Staff Specialist at RPA, and at Chris O’Brien Lifehouse and Associate Professor at the University of Sydney. He has a special interest in ovarian, breast, colorectal and upper gastrointestinal cancers and is involved in Phase I, II and III clinical trials for all of these cancers and is the PI in several breast and ovarian cancer trials. He has published more than 100 peer reviewed papers. He is the Chair of ANZGOG and is a member of the AGITG and ANZBCTG trials groups.
ASSOCIATE PROFESSOR ALISON BRAND
ANZGOG – Director, Medical Oncologist
Alison Brand is a gynaecological oncology surgeon, Director of Gynaecological Oncology at Westmead Hospital, Sydney, NSW and Clinical Assoc Prof at the University of Sydney. Alison has been involved in ANZGOG since it was established in 2000 and has since held key positions within the group. She was Chair of the group from 2012 to 2018. She is the Australian PI for the STATEC endometrial cancer surgical trial. She has chaired or been a member of several working parties for the development of national gynaecological cancer guidelines. She was Senior Editor for the International Journal of Gynaecological Cancer. She is passionate about participation in clinical trials as a way to improve the lives of women with gynaecological cancers, now and in the future.
Associate Professor Tarek Meniawy is a medical oncologist who subspecialises in melanoma, gynaecological cancers as well as early-phase clinical trials. He is a Clinical Senior Lecturer at the University of Western Australia, where has was awarded a PhD degree in 2016. A very active researcher, he is also one of 4 Principal Investigators at Linear Clinical Research, the only dedicated Phase I unit in Western Australia, and one of a handful of such dedicated units in Australia. Dr Meniawy is Chair of the ANZGOG Ovarian Tumour Working Group and serves on the Research Advisory Committee and OASIS Steering Committee. He is also a member of the statewide Western Australia Gynaecologic Cancer Service (WAGCS), as well as the WA Kirkbride Melanoma Advisory Service.
DR ALISON DAVIS
ANZGOG – Director, Chair Research Advisory Committee, Operations Executive Committee
Alison Davis is a Senior Staff Specialist in Medical Oncology at The Canberra Hospital and Conjoint Senior lecturer at the Australian National University. Her subspeciality areas include gynaecological and breast cancer and she is actively involved in clinical research in both areas. Her other interest areas include Cancer Genetics and end of life care. Alison has been involved with ANZGOG for many years and was Deputy Chair of the ANZGOG RAC for two years before becoming Chair in late 2017. She has also been a member of the ANZGOG Audit and ASM Committees, as well as a member of other regional and national organisations including Advisory Committee Pharmaceutical Medicines 2008-2015, ACT SE NSW Breast Cancer Treatment Group, Australian Breast Cancer Tissue Bank and is Chair of the Capital Region Cancer Services Morbidity and mortality committee.
DR PEARLY KHAW
ANZGOG – Director, Research Advisory Committee, Endometrial Tumour Group, Chair Quality Assurance Committee
Pearly Khaw is a Radiation Oncologist at the Peter MacCallum Cancer Centre. She is also a clinical researcher and is leading the Radiation Oncology Quality Assurance Program of the PORTEC-3 trial in Australia through the Trans-Tasman Radiation Oncology Group (TROG). Dr Khaw has been a reviewer for the International Journal of Gynecological Cancer, Journal of Medical Imaging and Radiation Oncology, and Practical Radiation Oncology. She was involved in the formation of the Special Interest Group for Radiation Oncologists practising in the area of Gynae-Oncology through the Royal Australian and New Zealand College of Radiologists.
PROFESSOR LINDA MILESHKIN
ANZGOG – Director, Operations Executive Committee, OASIS
Linda Mileshkin is a clinical researcher who has achieved productive research output whilst maintaining a significant and busy clinical role as a consultant medical oncologist, with a particular interest in the treatment of gynaecological and lung cancers, as well as the supportive care of people affected by cancer. She runs the only specialist Carcinoma of Unknown Primary clinic at the Peter MacCallum Cancer Centre. She is currently involved in multiple clinical research projects involving gynaecological and lung cancers, carcinoma of unknown primary (CUP), as well as Phase I trials in multiple tumour types. Linda is currently the international study chair for ICON9 and VIP.
PROFESSOR CLARE SCOTT
ANZGOG – Director, Ovarian Tumour Group, Annual Scientific Meeting Program Committee, OASIS
Clare Scott is a Medical Oncologist at the Royal Melbourne Hospital and Royal Women’s Hospital and Laboratory Head at the Walter and Eliza Hall Institute of Medical Research, studying drug resistance in ovarian cancer. She has 15 years’ experience in clinical cancer genetics, including working in Familial Cancer Clinics and in treating breast and ovarian cancer. In the lab, she focuses on ovarian biology, including the role of apoptosis in infertility and on developing targeted therapies for ovarian cancer in novel ovarian cancer models. She has been awarded a Clinical Fellowship from the Victorian Cancer Agency (2011) and
the Sir Edward Dunlop Cancer Research Fellowship from the Cancer Council Victoria (2012).
DR PAUL COHEN
ANZGOG – Director and Chair of ANZGOG’s Annual Scientific Meeting Committee
Paul Cohen is a clinician researcher at the Western Australian Gynaecological Cancer Service, King Edward Memorial Hospital, and St John of God Subiaco Hospital, Western Australia. He is a Clinical Assoc Prof at the University of Western Australia and Adjunct Prof at the Institute for Health Research, University of Notre Dame Australia. He is a co-investigator in a number of clinical trials. Paul is the current program chair of the ANZGOG Annual Scientific Meeting. He is a member of the Australian eviQ National Guidelines Cancer Genetics Reference Committee, ANZGOG Cervix Tumour Type Working Group, Australian Clinical Trial Alliance Impact and Implementation Committee, IGCS Education Committee and is a member of the Editorial Board of the International Journal of Gynecological Cancer.
DR MICHELLE WILSON
ANZGOG – New Zealand Director, Research Advisory Committee, Ovarian Tumour Working Group, OASIS
Dr Michelle Wilson is a medical oncologist who subspecialises in gynaecological cancers and early-phase clinical trials. She is the clinical director for Cancer and Blood Research at Auckland City Hospital. Dr Wilson is a very active researcher, and is also one of 4 Principal Investigators with the early phase Auckland Cancer Trials Centre. Dr Wilson’s research focus is geared towards early phase translational studies and clinical trial endpoints, in particular their utility and evolution in the era of precision oncology. She was awarded a medical doctorate on this topic in 2018 through the University of Auckland. Dr Wilson is a member of the ANZGOG Research Advisory Committee, Ovarian Tumour Working Group and OASIS Steering Committee.
MS WANDA LAWSON
ANZGOG – Consumer Director, Chair of Consumer Research Panel, Research Advisory Committee, Cervix Tumour Working Group
Ovarian cancer survivor
Ms Wanda Lawson is a retired Business and Change Management Consultant, previously running her own company in the delivery of business solutions. She joined the ANZGOG Consumer Community Committee in 2011 after several years as a member of Cancer Voices QLD. She was appointed to the Research Advisory Committee in 2012 and became the first Chair of the Consumer Research Panel in 2018 – a position she holds currently. She is a member of the ANZGOG Cervix Tumour Type Working Group and the ANZGOG Annual Scientific Meeting organising committee. Wanda is also an Associate Investigator on several gynaecological trials.
In 2004 she was diagnosed with ovarian cancer. Since then she has focused her skills on campaigning for better outcomes for women diagnosed with gynaecological cancers.
MR DAVID ROGERS
ANZGOG – Non-executive Director of Finance, Chair Audit Risk and Compliance Committee
David Rogers was with professional services firm KPMG for 37 years, including 27 years as a partner in the Australian firm. His career has included audit partner and lead partner for many significant companies in a wide range of sectors. In addition, David was a member of the firm’s National Board of directors for 6 years from 2005 to 2011 including two years as Chairman of the firm’s Audit Committee and was prior to his retirement leader of the firm’s global audit transformation project.
David is currently a Director and Vice Commodore of the Royal Motor Yacht Club Broken Bay and is also a member of the Western Sydney Local Health District Finance, Performance and Assets Committee.
MS RACHAEL SUTTON
ANZGOG – Director and Honorary Solicitor, Audit Risk and Compliance Committee
Rachael is a Partner in the Holman Webb Workplace Relations group and has 19 years’ experience in employment and workplace law. Rachael is experienced in all aspects of workplace laws and has a strong background in advising public and private sector employers. Rachael was admitted to practice law in October 1997 and has been a partner at Holman Webb since January 2012. She also specialises in food safety and labelling laws and has acted as a prosecutor for the NSW Food Authority for some 14 years. She now advises food businesses including start-ups in this area. Rachael has presented to many Boards of Directors and senior management teams on employment and work health and safety laws, what due diligence means and how best to comply. Rachael is a member of the NSW Law Society and Industrial Relations Society of NSW.